1st Quarter Results
AstraZeneca
25 April 2024
Q1 2024 results
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Revenue and…
71,710$
0,83%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Ihre wichtigsten Termine: Frische Q1-Zahlen von: Alphabet, Snap, Intel, AstraZeneca, Hermes und Nestle
© Foto: Rolf Vennenbernd/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten…
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease…
Day ahead: Sainsburys, Barclays, AstraZeneca
AstraZenecas CEOs pay has been the subject of much debate recently. See if Pascal Soriot is justifying his £18.7 million…
Britain’s Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut?
The Magnificent 7 will be hogging US financial news headlines over the coming weeks. Not to be confused with the…
ANGLE shares jump 30% on AstraZeneca tie-up
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to advance...…
ANGLE partners with AstraZeneca in groundbreaking oncology contract
…
AstraZeneca: What The Markets Missing
…
Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca
…
ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with AstraZeneca PLC (LSE:AZN) to enhance cancer drug...…